Tratamiento del estado epiléptico, consenso de expertos. Asociación Colombiana de Neurología, Comité de Epilepsia

  1. Vergara, Jean Paul 1
  2. Ladino, Lady 2
  3. Castro, Carlos Alberto 3
  4. Gómez, Bety 4
  5. Forero, Edwin 5
  6. Vargas, Juliana 6
  7. Gaona, Iván 7
  8. Lizcano, Angélica 8
  9. Mayor, Carlos 9
  10. Nariño, Daniel 10
  11. Ramírez, Sergio 11
  12. Suárez, Fabio 7
  13. Benjumea, Vanessa 4
  14. Espinosa, Camilo 12
  15. Martínez, Adriana 13
  16. Moreno, Julio 14
  17. Tolosa, Carlos 15
  18. Martínez, Paula 6
  19. Guio, Laura 16
  1. 1 Neurólogo-epileptólogo, Epidemiólogo clínico, Hospital San José. Bogotá, Colombia.
  2. 2 Neuróloga-epileptóloga, Hospital Pablo Tobón Uribe - Universidad de Antioquia. Medellín, Colombia.
  3. 3 Médico, epidemiólogo. SIIES Consultores, Investigación y Educación en Salud. Fundación Universitaria de Ciencias de la Salud. Bogotá, Colombia.
  4. 4 Neuróloga-epileptóloga neuromédica. Bogotá, Colombia.
  5. 5 Neuropediatra-epileptólogo Fundación Cardioinfantil. Bogotá, Colombia.
  6. 6 Neuróloga-epileptóloga, Hospital Militar Central. Bogotá, Colombia.
  7. 7 Neurólogo-epileptólogo, Fundación Cardioinfantil. Bogotá, Colombia.
  8. 8 Neuróloga-epileptóloga, Neurocentro. Bogotá, Colombia.
  9. 9 Neurólogo-epileptólogo, Fundación Santa Fe de Bogotá. Bogotá, Colombia.
  10. 10 Neurólogo-epileptólogo, Hospital San Ignacio. Bogotá, Colombia.
  11. 11 Neurólogo-neurofisiólogo, Hospital San José Infantil. Bogotá, Colombia.
  12. 12 Neurólogo-epileptólogo, Hospital Occidente de Kennedy. Bogotá, Colombia.
  13. 13 Neuróloga-epileptóloga Foscal - Foscal Internacional. Santander, Colombia.
  14. 14 Neurólogo-epileptólogo, Hospital San José Infantil. Bogotá, Colombia.
  15. 15 Neurólogo-epileptólogo, Clínica Imbanaco. Cali, Colombia.
  16. 16 Neuropediatra-epileptóloga, Hospital de la Misericordia. Bogotá, Colombia.
Show affiliations +
Journal:
Acta Neurológica Colombiana

ISSN: 2422-4022,  0120-8748

Year of publication: 2019

Volume: 35

Issue: 2

Pages: 74-88

Type: Article

DOI: 10.22379/24224022237 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Acta Neurológica Colombiana

Sustainable development goals

Abstract

INTRODUCTION: Status epilepticus is a condition caused by failure in the mechanisms of suppression of epileptic seizures. It is considered a neurological emergency, and mortality varies between 2 % to 50 % according to the age group. Due to the above, it is relevant that health professionals know the characteristics of SE in order to stabilize the patient. OBJECTIVE: To define a series of propositions for the treatment of SE, as a result of consensus by common agreement of experts in epilepsy, taking into account the Colombian context. METHODS: A formal consensus of experts was carried out with 16 adult and pediatric neurologists-epilep-tologists. The questions and propositions were reviewed in two phases, where they were graded and agreed by the participants. RESULTS: Fifteen questions were evaluated on the management of status epilepticus. Relevant bibliographic references were considered by the experts according to the Colombian context. CONCLUSIONS: As results of this consensus we present a series of propositions for the treatment of status epilepticus for the primary level of care and high complexity level of care in order to improve the patient's prognosis, according to the Colombian context.

Bibliographic References

  • Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56(10):1515-23.
  • Smith DM, McGinnis EL, Walleigh DJ, Abend NS. Management of status epilepticus in children. J Clin Med. 2016;5(4):47.
  • Ruiz NP, Castellanos J. Estado epiléptico en condiciones especiales. Acta Neurol Colomb. 2011;27(1 Supl. 1):68-74.
  • Corral-Ansa L, Herrero JI, Falip M, Aiguabella M. Estatus epiléptico. Med Intensiva. 2008;32(4):174-82.
  • Chávez JL, Mancera OG. Estatus epiléptico en Colombia: Análisis descriptivo de serie de casos. Rev Ecuat Neurol. 2017;26(1):9-16.
  • DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46(4):1029-35.
  • Hiyoshi T, Yagi K. Epilepsy in the elderly. Epilepsia. 2000;41(Supl. 9):31-5.
  • Chin RF, Neville BG, Peckham C, Bedford H, Wade A, Scott RC, et al. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet. 2006;368(9531):222-9.
  • Raspall-Chaure M, Chin RFM, Neville BG, Bedford H, Scott RC. The epidemiology of convulsive status epilepticus in children: a critical review. Epilepsia. 2007;48(9):1652-63.
  • Sahin M, Menache CC, Holmes GL, Riviello JJ. Outcome of severe refractory status epilepticus in children. Epilepsia. 2001;42(11):1461-7.
  • Gilbert DL, Gartside PS, Glauser TA. Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: a meta-analysis. J Child Neurol. 1999;14(9):602-9.
  • Kim SJ, Lee DY, Kim JS. Neurologic outcomes of pediatric epileptic patients with pentobarbital coma. Pediatr Neurol. 2001;25(3):217-20.
  • Trinka E, Kalviainen R. 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure. 2017;44:65-73.
  • International League Against Epilepsy - ILAE. A definition and classification of status epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus. EE.UU. 2016. Disponible en: https://www.ilae.org/patient-care/status-epilepticus
  • American Heart Association - AHA. Reanimación cardiopulmunar - ABC EE.UU 2017. Disponible en: https://eccguidelines.heart.org/index.php/circulation/cpr-ecc-guidelines-2/
  • Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48-61.
  • Bernater R, Calle A, Campanille V, Martínez O, Paoli N, Perassolo M, et al. Status epiléptico: actualización en consideraciones clínicas y guías terapéuticas. Neurolog Argent. 2013;5(2):117-28.
  • Brigo F, Bragazzi NL, Igwe SC, Nardone R, Trinka E. Topiramate in the treatment of generalized convulsive status epilepticus in adults: a systematic review with individual patient data analysis. Drugs. 2017;77(1):67-74.
  • Brigo F, Bragazzi NL, Bacigaluppi S, Nardone R, Trinka E. Is intravenous lorazepam really more effective and safe than intravenous diazepam as first-line treatment for convulsive status epilepticus? A systematic review with meta-analysis of randomized controlled trials. Epilepsy Behav 2016;64(Pt A):29-36.
  • Brigo F, Bragazzi N, Nardone R, Trinka E. Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus. Epilepsy Behav. 2016;64(Pt A):110-5.
  • Pisani F, Pavlidis E. What is new: Talk about status epilepticus in the neonatal period. Eur J Paediatr Neurol. 2018;22(5):757-62.
  • Yasiry Z, Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure. 2014;23(3):167-74.
  • McTague A, Kneen R, Kumar R, Spinty S, Appleton R. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital. Seizure. 2012;21(7):529-34.
  • Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43(2):146-53.
  • Cabrera Kang CM, Gaspard N, LaRoche SM, Foreman B. Survey of the diagnostic and therapeutic approach to new-onset refractory status epilepticus. Seizure. 2017;46:24-30.
  • Vasquez A, Farias-Moeller R, Tatum W. Pediatric refractory and super-refractory status epilepticus, Seizure: Eur J Epilepsy (2018), https://doi.org/10.1016/j.seizure.2018.05.012
  • Chiusolo F, Diamanti A, Bianchi R, Fusco L, Elia M, Capriati T, et al. From intravenous to enteral ketogenic diet in PICU: A potential treatment strategy for refractory status epilepticus. Eur J Paediatr Neurol. 2016;20(6):843-7.
  • Bogaarts JG, Hilkman DM, Gommer ED, van Kranen-Mastenbroek VH, Reulen JP. Improved epileptic seizure detection combining dynamic feature normalization with EEG novelty detection. Med Biol Eng Comput. 2016;54(12):1883-92.
  • Yeary J, Garavaglia J, McKnight R, Smith M. Change in management of status epilepticus with the addition of neurointensivistled neurocritical care team at a rural academic medical center. Hosp Pharm. 2018;53(5):303-7.
  • Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3-23.
  • Jadeja NM, Lee J. F22. Duration of burst suppression in status epilepticus: A retrospective analysis. Clin Neurophysiol. 2018;129:e74-e5.
  • Datar S. New developments in refractory status epilepticus. Neurosurg Clin N Am. 2018;29(2):273-9.
  • Wolfgang G. Muhlhofer Duration of therapeutic coma and outcome of refractory status epilepticus . Epilepsia. 2019;1-14.
  • Sutter R, Dittrich T, Semmlack S, Ruegg S, Marsch S, Kaplan PW. Acute systemic complications of convulsive status epilepticus-a systematic review. Crit Care Med. 2018;46(1):138-45.
  • Sutter R, Kaplan PW, Rüegg S. Outcome predictors for status epilepticus-what really counts. Nat Rev Neurol. 2013;9(9):525-34.
  • Struck AF, Osman G, Rampal N, Biswal S, Legros B, Hirsch LJ, et al. Time-dependent risk of seizures in critically ill patients on continuous electroencephalogram. Ann Neurol. 2017;82(2):177-85.
  • Al-Mufti F, Claassen J. Neurocritical care: status epilepticus review. Crit Care Clin. 2014;30(4):751-64.
  • Shorvon SD. The etiologic classification of epilepsy. Epilepsia. 2011;52(6):1052-7.
  • Bodenant M, Moreau C, Sejourné C, Auvin S, Delval A, Cuisset JM, et al. Interest of the ketogenic diet in a refractory status epilepticus in adults. Rev Neurol (Paris). 2008;164(2):194-9.
  • Cervenka MC, Hartman AL, Venkatesan A, Geocadin RG, Kossoff EH. The ketogenic diet for medically and surgically refractory status epilepticus in the neurocritical care unit. Neurocrit Care. 2011;15(3):519-24.
  • Nam SH, Lee BL, Lee CG, Yu HJ, Joo EY, Lee J, et al. The role of ketogenic diet in the treatment of refractory status epilepticus. Epilepsia. 2011;52(11):e181-4.
  • Wusthoff CJ, Kranick SM, Morley JF, Christina Bergqvist AG. The ketogenic diet in treatment of two adults with prolonged nonconvulsive status epilepticus. Epilepsia. 2010;51(6):1083-5.
  • Thakur KT, Probasco JC, Hocker SE, Roehl K, Henry B, Kossoff EH, et al. Ketogenic diet for adults in super-refractory status epilepticus. Neurology. 2014;82(8):665-70.
  • Caraballo R, Darra F, Reyes G, Armeno M, Cresta A, Mestre G, et al. The ketogenic diet in patients with myoclonic status in non-progressive encephalopathy. Seizure. 2017;51:1-5.
  • Payne NE, Cross JH, Sander JW, Sisodiya SM. The ketogenic and related diets in adolescents and adults-- a review. Epilepsia. 2011;52(11):1941-8.
  • Strzelczyk A, Steinig I, Willems LM, Reif PS, Senft C, Voss M, et al. Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitals. Epilepsy Behav. 2017;70(Pt A):177-81.
  • Nariño D, Quintero R. Definición, clasificación y semiología del estado epiléptico. Conceptos actuales. Act Neurol Colomb. 2011;27(1):1-10.
  • Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB. Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol. 2008;255(10):1561-6.
  • Leitinger M, Holler Y, Kalss G, Rohracher A, Novak HF, Hofler J, et al. Epidemiology-based mortality score in status epilepticus (EMSE). Neurocrit Care. 2015;22(2):273-82.
  • Gao Q, Ou-Yang T-p, Sun X-l, Yang F, Wu C, Kang T, et al. Prediction of functional outcome in patients with convulsive status epilepticus: the END-IT score. Critical Care. 2016;20:46.
  • Cheng JY. Mortality prediction in status epilepticus with the APACHE II score. J Intensive Care Soc. 2017;18(4):310-7.
  • Giovannini G, Monti G, Tondelli M, Marudi A, Valzania F, Leitinger M, et al. Mortality, morbidity and refractoriness prediction in status epilepticus: Comparison of STESS and EMSE scores. Seizure. 2017;46:31-7.
  • Bénit C, Vecht C. Seizures and cancer: drug interactions of anticonvulsants with chemotherapeutic agents, tyrosine kinase inhibitors and glucocorticoids. Neurooncol Pract. 2016;6(4):245-60.
  • Carlson C, Anderson CT. Special issues in epilepsy: the elderly, the immunocompromised, and bone health. Continuum (Minneap Minn). 2016;22(1 Epilepsy):246-61.
  • Lacerda G, Krummel T, Sabourdy C, Ryvlin P, Hirsch E. Optimizing therapy of seizures in patients with renal or hepatic dysfunction. Neurology. 2006;67(12 Supl. 4):S28-33.
  • Ospina AV, Bruges R, Lema M, Lima Lopes G, Gómez R, Lombana M, et al. Tratamiento de cáncer de pulmón metas-tásico (estadio IV) de célula no pequeña. Consenso de expertos, Asociación Colombiana de Hematología y Oncología (ACHO). Rev Col Hem Onc. 2018;5(1):61-71.
  • Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51(4):676-85.
  • Meierkord H, Holtkamp M. Non-convulsive status epilepti-cus in adults: clinical forms and treatment. Lancet Neurol. 2007;6(4):329-39.
  • Belluzzo M, Furlanis G, Stragapede L, Monti F. Role of comorbidities and in-hospital complications in short-term status epilepticus outcome. Clin Neurol Neurosurg. 2017;154:13-8.
Data source: Dialnet